Yungjin Pharm Co Ltd
KRX:003520
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Yungjin Pharm Co Ltd
KRX:003520
|
KR |
|
AdvancedAdvT Ltd
LSE:ADVT
|
UK |
|
Adneo Ltd
ASX:AD1
|
AU |
|
S
|
Solution Group Bhd
KLSE:SOLUTN
|
MY |
|
Liberty Latin America Ltd
F:1LLC
|
US |
|
R
|
Resilient Reit Ltd
JSE:RES
|
ZA |
|
CH Robinson Worldwide Inc
NASDAQ:CHRW
|
US |
|
Tasfoods Ltd
ASX:TFL
|
AU |
|
Accentis NV
F:D1Z
|
BE |
|
W
|
Wartsila Oyj Abp
XMUN:MTA
|
FI |
|
S
|
Sandoz Group AG
SIX:SDZ
|
CH |
Bankruptcy Probability
Yungjin Pharm Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Yungjin Pharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
|
Yungjin Pharm Co Ltd
KRX:003520
|
188.9B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
615.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
365.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
360.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
192.3B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
269B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
168.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Yungjin Pharm Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Yungjin Pharm Co Ltd has total debt of 38.3B KRW. This includes both short-term (0 KRW) and long-term (38.3B KRW) debt.
You can find a full breakdown on its Balance Sheet.